Standout Papers

Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection 2013 2026 2017 2021 581
  1. Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection (2013)
    Sharon Walmsley, Antonio Antela et al. New England Journal of Medicine

Immediate Impact

1 from Science/Nature 61 standout
Sub-graph 1 of 18

Citing Papers

Potential Clinical and Economic Impacts of Cutbacks in the President’s Emergency Plan for AIDS Relief Program in South Africa
2025 Standout
Platinum Nanoparticles Regulated V2C MXene Nanoplatforms with NIR‐II Enhanced Nanozyme Effect for Photothermal and Chemodynamic Anti‐Infective Therapy
2024 Standout
4 intermediate papers

Works of Catherine Granier being referenced

Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection
2013 Standout

Author Peers

Author Last Decade Papers Cites
Catherine Granier 897 694 263 10 960
Hui C. Liu 860 612 284 12 979
Hadewych J. M. ter Hofstede 722 363 402 15 1.0k
Michael Aboud 929 691 395 31 1.0k
Martin Gartland 786 628 258 19 850
Gordon Crofoot 789 500 277 27 952
Hannah Green 610 534 183 27 939
Abby Shevitz 627 416 584 26 989
Roberto Ortiz 952 619 241 16 1.0k
Edmund Wilkins 587 435 299 24 755
Cheryl McDonald 607 421 207 27 750

All Works

Loading papers...

Rankless by CCL
2026